Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx

Agriculture & Biology

• Human immunodeficiency virus 100%
• micrococcal nuclease 69%
• virion 67%
• Human immunodeficiency virus 2 30%
• proteins 23%
• chloramphenicol acetyltransferase 18%
• Human immunodeficiency virus 1 17%
• virus-like particles 12%
• Simian immunodeficiency virus 6%
• proviruses 6%
• Vaccinia virus 6%
• viruses 6%
• polyproteins 5%
• response elements 5%
• gene fusion 5%
• terminal repeat sequences 5%
• proteinase inhibitors 5%
• phages 4%
• packaging 4%
• Western blotting 4%
• cleavage (chemistry) 4%
• open reading frames 3%
• proteinases 3%
• sucrose 3%
• antibodies 3%
• synthesis 2%
• DNA 2%
• enzymes 2%
• genes 1%

Medicine & Life Sciences

• Micrococcal Nuclease 86%
• Virion 67%
• Proteins 26%
• HIV-2 21%
• Chloramphenicol O-Acetyltransferase 21%
• vpr Gene Products 18%
• gag Gene Products 14%
• HIV-1 14%
• Human immunodeficiency virus 2 vpr protein 13%
• HIV 11%
• Bacteriophage lambda 7%
• HIV Protease Inhibitors 7%
• HIV Long Terminal Repeat 7%
• Human Immunodeficiency Virus Proteins 7%
• Western Blotting 7%
• Bacterial Genes 7%
• Viruses 7%
• Proviruses 7%
• Simian Immunodeficiency Virus 6%
• Vaccinia virus 6%
• Product Packaging 6%
• Gene Fusion 6%
• Response Elements 5%
• Sucrose 5%
• Open Reading Frames 5%
• Digestion 4%
• Antiviral Agents 4%
• Peptide Hydrolases 4%
• DNA 3%
• Antibodies 3%
• Enzymes 2%
• In Vitro Techniques 2%